# Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants in Mexico

> **NCT00708682** · PHASE3 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 225 (actual)

## Conditions studied

- Vaccines, Pneumococcal

## Interventions

- **BIOLOGICAL:** 13-valent pneumococcal conjugate vaccine

## Key facts

- **NCT ID:** NCT00708682
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 225 (ACTUAL)
- **Last updated:** 2011-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00708682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00708682, "Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants in Mexico". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00708682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*